Protective effects of neurotrophin-4/5 and transforming growth factor-α on striatal neuronal phenotypic degeneration after excitotoxic lesioning with quinolinic acid

Neuroscience

Volumn 78, Issue 1, 1997, Pages 73-86

  Alexi, T ^a,b   Venero, J L ^a   Hefti, F ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

calbindin; calretinin; GABAergic; Huntington's disease; neurotrophic factor; parvalbumin

Indexed keywords

CALBINDIN; CALRETININ; EXCITOTOXIN; GLUTAMATE DECARBOXYLASE; NEUROPROTECTIVE AGENT; NEUROTROPHIN; PARVALBUMIN; QUINOLINIC ACID; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE DEHYDROGENASE; TRANSFORMING GROWTH FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN INJURY; CONTROLLED STUDY; CORPUS STRIATUM; FEMALE; GABAERGIC SYSTEM; HUNTINGTON CHOREA; IMMUNOCYTOCHEMISTRY; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0030892073     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(97)83046-1     Document Type: Article

References (113)

1. Alexi T. and Hefti F. (1993) Trophic actions of transforming growth factor α on mesencephalic dopaminergic neurons developing in culture. Neuroscience 55, 903-918.
2. Anchan R. M., Reh T. A., Angello J., Balliet A. and Walker M. (1991) EGF and TGFα stimulate retinal neuroepithelial cell proliferation in vitro. Neuron 6, 923-936.
3. Arai H., Emson P. C., Mountjoy C. Q., Carassco L. H. and Heizmann C. W. (1987) Loss of parvalbumin-immunoreactive neurons from cortex in Alzheimer-type dementia. Brain Res. 418, 164-169.
4. Ardelt A. A., Flaris N. A. and Roth K. A. (1994) Neurotrophin-4 selectively promotes survival of striatal neurons in organotypic slice culture. Brain Res. 647, 340-344.
5. Baimbridge K. G., Celio M. R. and Rogers J. H. (1992) Calcium-binding proteins in the nervous system. Trends Neurosci. 15, 303-308.
6. Bazzett T. J., Becker J. B., Kaatz K. W. and Albin R. L. (1993) Chronic intrastriatal dialytic administration of quinolinic acid produces selective neuronal degeneration. Expl Neurol. 120, 177-185.
7. Beal M. F., Kowall N. W., Ellison D. W., Mazurek M. F., Swartz K. J. and Martin J. B. (1986) Replication of the neurochemical characteristics of Hungtington's disease by quinolinic acid. Nature 321, 168-171.
8. Beal M. F., Ferrante R. J., Swartz K. J. and Kowall N. W. (1991) Chronic quinolinic acid lesions in rats closely resemble Huntington's disease. J. Neurosci. 11, 1649-1659.
9. Bennett B. D. and Bolam J. P. (1993) Characterization of calretinin-immunoreactive structures in the striatum of the rat. Brain Res. 609, 137-148.
10. 28K-immunoreactive neurons in the striatum of the rat. Brain Res. 610, 305-310.
11. Berardi N., Domenici L., Parisi V., Pizzorusso T., Cellerino A. and Maffei L. (1993) Monocular deprivation effects in the rat visual cortex and lateral geniculate nucleus are prevented by nerve growth factor (NGF). I. Visual cortex. Proc. R. Soc. Lond. Ser. B, Biol. Sci. 251, 17-23.
12. Berkemeier L. R., Winslow J. W., Kaplan D. R., Nikolics K., Goeddel D. V. and Rosenthal A. (1991) Neurotrophin-5: a novel neurotrophic factor that activates trk and trkB. Neuron 7, 857-866.
13. Bird E. D. and Iversen L. L. (1974) Huntington's chorea: post-mortem measurement of glutamic acid decarboxylase, choline acetyltransferase and dopamine in basal ganglia. Brain 97, 457-472.
14. 28K immunostaining, following developmental hypoxia-ischemia. Neuroscience 56, 305-315.
15. Celio M. R. (1990) Calbindin D-28k and parvalbumin in the rat nervous system. Neuroscience 35, 375-475.
16. Cheng B. and Mattson M. P. (1994) NT-3 and BDNF protect CNS neurons against metabolic/excitotoxic insults. Brain Res. 640, 56-67.
17. Cheng B., Christakos S. and Mattson M. P. (1994) Tumor necrosis factors protect neurons against metabolic-excitotoxic insults and promote maintenance of calcium homeostasis. Neuron 12, 139-153.
18. Choi D. W. (1988) Calcium-mediated neurotoxicity: relationship to specific channel types and role in ischemic damage. Trends Neurosci. 11, 465-469.
19. Christakos S., Gabrielides C. and Rhoten W. B. (1989) Vitamin D-dependent calcium binding proteins: chemistry, distribution, functional considerations and molecular biology. Endocr. Rev. 10, 3-26.
20. Collazo D., Takahashi H. and McKay R. D. (1992) Cellular targets and trophic functions of neurotrophin-3 in the developing rat hippocampus. Neuron 9, 643-656.
21. Cowan R. L., Wilson C. J., Emson P. C. and Heizmann C. W. (1990) Parvalbumin-containing GABAergic interneurons in the rat neostriatum. J. comp. Neurol. 302, 197-205.
22. Davies S. W. and Roberts P. J. (1987) No evidence for preservation of somatostatin-containing neurons after intrastriatal injections of quinolinic acid. Nature 327, 326-329.
23. Davies S. W. and Beardsall K. (1992) Nerve growth factor selectively prevents excitotoxin induced degeneration of striatal cholinergic neurons. Neurosci. Lett. 140, 161-164.
24. Dawbarn D., DeQuidt M. E. and Emson P. L. (1985) Survival of basal ganglia neuropeptide Y-somatostatin neurons in Huntington's disease. Brain Res. 340, 251-260.
25. DiFiglia M., Christakos S. and Aronin N. (1989) Ultrastructural localization of immunoreactive Calbindin-D28k in the rat and monkey basal ganglia, including subcellular distribution with colloidal gold labeling. J. comp. Neurol. 279, 653-665.
26. Escandon E., Soppet D., Rosenthal A., Mendoza-Ramierez J.-L., Szonyi E., Burton L. E., Henderson C. E., Parada L. F. and Nikolics K. (1994) Regulation of neurotrophin receptor expression during embryonic and postnatal development. J. Neurosci. 14, 2054-2068.
27. Fallon J. H., Annis C. M., Gentry L. E., Twardzik D. R. and Loughlin S. E. (1990) Localization of cells containing transforming growth factor α precursor immunoreactivity in the basal ganglia of the adult rat brain. Growth Factors 2, 241-250.
28. Ferrante R. J., Kowall N. W., Beal M. F., Richardson E. P. Jr, Martin J. B. (1985) Selective sparing of a class of striatal neurons in Huntington's disease. Science 230, 561-563.
29. Ferrante R. J. and Kowall N. W. (1987) Tyrosine hydroxylase-like immunoreactivity is distributed in the matrix compartment of normal human and Huntington's disease striatum. Brain Res. 416, 141-146.
30. Ferrante R. J., Beal M. F., Kowall N. W., Richardson E. P. Jr, Martin J. B. (1987) Sparing of acetylcholinesterase-containing striatal neurons in Huntington's disease. Brain Res. 411, 162-166.
31. Ferrante R. J., Kowall N. W. and Richardson E. P. Jr (1991) Proliferative and degenerative changes in striatal spiny neurons in Hungtington's disease: a combined study using the section-Golgi method and calbindin D28k immunocytochemistry. J. Neurosci. 11, 3877-3887.
32. Ferrante R. J., Kowall N. W., Cipolloni P. B., Storey E. and Beal M. F. (1993) Excitotoxin lesions in primates as a model for Huntington's disease: histopathologic and neurochemical characterization. Expl Neurol. 119, 46-71.
33. Ferrer L, Casas R. and Rivera R. (1993) Parvalbumin-immunoreactive cortical neurons in Creutzfeldt-Jakob disease. Ann. Neurol. 34, 864-866.
34. Ferriero D. M., Arcavi L. J., Sagar S. M., McIntosh T. K. and Simon R. P. (1988) Selective sparing of NADPH-diaphorase neurons in neonatal hypoxia-ischemia. Ann. Neurol. 24, 670-676.
35. Figueredo-Cardenas G., Anderson K. D., Chen Q., Veenman C. L. and Reiner A. (1994) Relative survival of striatal projection neurons and interneurons after intrastriatal injection of quinolinic acid in rats. Expl Neurol. 129, 37-56.
36. Forloni G. L., Angeretti N., Rizzi M. and Vezzani A. (1992) Chronic infusion of quinolinic acid in rat striatum: effects on discrete neuronal populations. J. neural. Sci. 108, 129-136.
37. Freund T. F., Buzsaki G., Leon A., Baimbridge K. G. and Somogyi P. (1990) Relationship of neuronal vulnerability and calcium binding protein immunoreactivity in ischemia. Expl Brain Res. 83, 55-66.
38. Friedman W. J., Ibanez C. F., Hallbook F., Persson H., Cain L. D., Dreyfus C. F. and Black I. B. (1993) Differential actions of neurotrophins in the locus coeruleus and basal forebrain. Expl Biol. 119, 72-78.
39. Frim D. M., Yee W. M. and Isacson O. (1993) NGF reduces striatal excitotoxic neuronal loss without affecting concurrent neuronal stress. NeuroReport 4, 655-658.
40. 28K and of the dopaminergic mesocortical projections in Weaver mutant mice. Neuroscience 61, 293-305.
41. Gerfen C. R., Baimbridge K. G. and Miller J. J. (1985) The neostriatal mosaic: compartmental distribution of calcium-binding protein and parvalbumin in the basal ganglia of the rat and monkey. Proc. natn. Acad. Sci. U.S.A. 82, 8780-8784.
42. 28K-containing cells. In Neurotoxins and Neurodegenerative Disease (eds Langston J. W. and Young A.), Vol. 648, pp. 42-62. Annals of the New York Academy of Science.
43. Geula C., Schatz C. R. and Mesulam M. M. (1993) Differential localization of NADPH-diaphorase and calbindin-D28k within the cholinergic neurons of the basal forebrain, striatum and brainstem in the rat, monkey, baboon and human. Neuroscience 54, 461-476.
44. Gibb W. R. G. (1992) Melanin, tyrosine hydroxylase, calbindin and substance P in the human midbrain and substantia nigra in relation to nigrostriatal projections and differential neuronal susceptibility in Parkinson's disease. Brain Res. 581, 283-291.
45. Hadjiconstantinou M., Fitkin J. G., Dalia A. and Neff N. H. (1991) Epidermal growth factor enhances striatal dopaminergic parameters in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mouse. J. Neurochem. 57, 479-482.
46. Harrington K. M. and Kowall N. W. (1991) Parvalbumin immunoreactive neurons resist degeneration in Huntington's disease striatum. J. Neuropath. exp. Neurol. 50, 309.
47. Hefti F. (1994) Neurotrophic factor therapy for nervous system degenerative disease. J. Neurobiol. 25, 1418-1435.
48. 2+-binding proteins in human neurodegenerative disorders. Trends Neurosci. 15, 259-264.
49. 28K-like immunoreactivity in catecholaminergic cell groups of the human midbrain: normal distribution and distribution in Parkinson's disease. Neurodegeneration 1, 83-93.
50. Hof P. R. and Morrison J. H. (1991) Neocortical neuronal subpopulations labeled by a monoclonal antibody to calbindin exhibit differential vulnerability in Alzheimer's disease. Expl Neurol. 111, 293-301.
51. Hollmann M. and Heinemann S. (1994) Cloned glutamatergic receptors. A. Rev. Neurosci. 17, 31-108.
52. Holtzman D. M., Kilbridge J., Bredt D. S., Black S. M., Li Y., Clary D. O., Reichardt L. F. and Mobley W. C. (1994) NOS induction by NGF in basal forebrain cholinergic neurons: evidence for regulation of brain NOS by a neurotrophin. Neurobiol. Dis. 1, 51-60.
53. Hoogeveen A. T., Willemsen R., Meyer N., de Rooij K. E., Roos R. A. C., van Ommen G.-J. B. and Galjaard H. (1993) Characterization and localization of the Hungtington disease gene product. Human molec. Genet. 2, 2069-2073.
54. Hyman C., Juhasz M., Jackson C., Wright P., Ip N. Y. and Lindsay R. M. (1994) Overlapping and distinct actions of the neurotrophins BDNF, NT-3 and NT-4/5 on cultured dopaminergic and GABAergic neurons of the ventral mesencephalon. J. Neurosci. 14, 335-347.
55. Hynes M. A., Poulsen K., Armanini M., Berkemeier L., Phillips H. and Rosenthal A. (1994) Neurotrophin-4/5 is a survival factor for embryonic midbrain dopaminergic neurons in enriched cultures. J. Neurosci. Res. 37, 144-154.
56. Iacopino A. M. and Christakos S. (1990) Specific reduction of calcium-binding protein (28-kilodalton calbindin-D) gene expression in aging and neurodegenerative diseases. Proc. natn. Acad. Sci. U.S.A. 87, 4078-4082.
57. 28K-containing neurons in animal models of neurodegeneration: possible protection from excitotoxicity. Molec. Brain Res. 13, 251-261.
58. 28K: a potential neuroprotective protein. Neurodegeneration 3, 1-20.
59. Ichimiya Y., Emson P. C., Mountjoy C. Q., Lawson D. E. and lizuka R. (1989) Calbindin-immunoreactive cholinergic neurons in the nucleus basalis of Meynert in Alzheimer-type dementia. Brain Res. 499, 402-406.
60. Ip N. Y., Li Y., van de Stadt I., Panayotatos N., Alderson R. F. and Lindsay R. M. (1991) Ciliary neurotrophic factor enhances neuronal survival in embryonic rat hippocampal cultures. J. Neurosci. 11, 3124-3134.
61. Ip N. Y., Li Y., Yancopoulos G. D. and Lindsay R. M. (1993) Cultured hippocampal neurons show responses to BDNF, NT-3, and NT-4, but not NGF. J. Neurosci. 13, 3394-3405.
62. Jacobowitz D. M. and Winsky L. (1991) Immunocytochemical localization of calretinin in the forebrain of the rat. J. comp. Neurol. 304, 198-218.
63. Kaufman D. L., Houser C. R. and Tobin A. J. (1991) Two forms of the γ-aminobutyric acid synthetic enzyme glutamate decarboxylase have distinct intraneuronal distributions and cofactor interactions. J. Neurochem. 56, 720-723.
64. Kawaguchi Y., Wilson C. J., Augood S. J. and Emson P. C. (1995) Striatal interneurons: chemical, physiological and morphological characterization. Trends Neurosci. 18, 527-535.
65. Kita H., Kosaka T. and Heizmann C. W. (1990) Parvalbumin-immunoreactive neurons in the rat neostriatum: a light and electron microscopic study. Brain Res. 536, 1-15.
66. 28K as a marker for the degeneration of the striatonigral pathway in Huntington's disease. Brain Res. 525, 209-214.
67. Knüsel B., Beck K. D., Winslow J. W., Rosenthal A., Burton L. E., Widmer H. R., Nikolics K. and Hefti F. (1992) Brain-derived neurotrophic factor administration protects basal forebrain cholinergic but not nigral dopaminergic neurons from degenerative changes after axotomy in the adult rat brain. J. Neurosci. 12, 4391-4402.
68. Kornblum H. I., Chugani H. T., Tatsukawa K. and Gall C. M. (1994) Cerebral hemidecortication alters expression of transforming growth factor alpha mRNA in the neostriatum of developing rats. Molec. Brain Res. 21, 107-114.
69. Kornblum H. I., Gall C. M., Seroogy K. B. and Lauterborn J. C. (1995) A subpopulation of striatal GABAergic neurons expresses the epidermal growth factor receptor. Neuroscience 69, 1025-1029.
70. Korsching S. (1993) The neurotrophic factor concept: a reexamination. J. Neurosci. 13, 2739-2748.
71. Kubota Y. and Kawaguchi Y. (1993) Spatial distributions of chemically identified intrinsic neurons in relation to patch and matrix compartments of rat neostriatum. J. comp. Neurol. 332, 499-513.
72. Kubota Y., Mikawa S. and Kawaguchi Y. (1993) Neostriatal GABAergic interneurons contain NOS, calretinin or parvalbumin. NeuroReport 5, 205-208.
73. Lavoie B. and Parent A. (1991) Dopaminergic neurons expressing calbindin in normal and parkinsonian monkeys. NeuroReport 2, 601-604.
74. Lazar L. M. and Blum M. (1992) Regional distribution and developmental expression of epidermal growth factor and transforming growth factor a mRNA in mouse brain by a quantitative nuclease protection assay. J. Neurosci. 12, 1688-1697.
75. Li S.-H., Schilling G., Young W. S., Li X.-J., Margolis R. L., Stine O. C., Wagster M. V., Abbott M. H., Franz M. L., Ranen N. G., Folstein S. E., Hedreen J. C. and Roos C. A. (1993) Huntington's disease gene (IT15) is widely expressed in human and rat tissues. Neuron 11, 985-993.
76. Lindholm D., Castren E., Tsoulfas P., Kolbeck R., Berzaghi M. da P., Leingartner A., Heisenberg C. P., Tesarollo L. and Parada L. F. (1993) Neurotrophin-3 induced by tri-iodothyronine in cerebellar granule cells promotes Purkinje cell differentiation. J. Cell Biol. 122, 443-450.
77. Loughlin S. E. and Fallon J. H. (eds) (1993) Neurotrophic Factors. Academic, New York.
78. 28K in cultured hippocampal neurons. Neuron 6, 41-51.
79. r 67000) in the basal ganglia of the rat. J. comp. Neurol. 318, 245-254.
80. Merlio J.-P., Ernfors P., Jaber M. and Persson H. (1992) Molecular cloning of rat trkC and distribution of cells expressing messenger RNAs for members of the trk family in the rat central nervous system. Neuroscience 51, 513-532.
81. Mizuno K., Carnahan J. and Nawa H. (1994) Brain-derived neurotrophic factor promotes differentiation of striatal GABAergic neurons. Devl Biol. 165, 243-256.
82. Nawa H., Bessho Y., Carnhan J., Nakanishi S. and Mizuno K. (1993) Regulation of neuropeptide expression in cultured cerebral cortical neurons by brain-derived neurotrophic factor. J. Neurochem. 60, 772-775.
83. Nawa H., Pelleymounter M. A. and Carnahan J. (1994) Intraventricular administration of BDNF increases neuropeptide expression in newborn rat brain. J. Neurosci. 13, 3751-3765.
84. 2+-binding protein parvalbumin. Neurosci. Lett. 105, 263-268.
85. Norman A. B., Ford L. M. and Sanberg P. R. (1991) Differential loss of neurochemical markers following quinolinic acid-induced lesions of rat striatum. Expl Neurol. 114, 132-135.
86. Nozaki K., Finkelstein S. P. and Beal M. F. (1993) Basic fibroblast growth factor protects against hypoxia-ischemia and NMDA neurotoxicity in neonatal rats. J. cerebr. Blood Flow Metab. 13, 221-228.
87. Otto D. and Unsicker K. (1990) Basic FGF reverses chemical and morphological deficits in the nigrostriatal system of MPTP-treated mice. J. Neurosci. 10, 1912-1921.
88. Patterson P. H. and Nawa H. (1993) Neuronal differentiation factors/cytokines and synaptic plasticity. Cell/Neuron 72/10 Suppl., 123-137.
89. Qin Y., Soghomonian J.-J. and Chesselet M.-F. (1992) Effects of quinolinic acid on messenger RNAs encoding somatostatin and glutamic acid decarboxylases in the striatum of adult rats. Expl Neurol. 115, 200-211.
90. Résibois A. and Rogers J. H. (1992) Calretinin in rat brain: an immunohistochemical study. Neuroscience 46, 101-134.
91. Roberts R. C., Ahn A., Swartz K. J., Beal M. F. and DiFiglia M. (1993) Intrastriatal injections of quinolinic acid or kainic acid: differential patterns of cell survival and the effects of data analysis on outcome. Expl Neurol. 124, 274-282.
92. Sauer H., Campbell K., Wiegand S. J., Lindsay R. M. and Bjorklund A. (1994) Brain-derived neurotrophic factor enhances striatal neuropeptide expression in both the intact and the dopamine-depleted rat striatum. NeuroReport 5, 609-612.
93. Scharfman H. E. and Schwartzkroin P. A. (1989) Protection of dentate hilar cells from prolonged stimulation by intracellular calcium chelation. Science 246, 257-260.
94. Schmidt-Kastner R., Heim C. and Sontag K. H. (1991) Damage of substantia nigra pars reticulata during pilocarpine-induced status epilepticus in the rat: immunohistochemical study of neurons, astrocytes and serum-protein extravasation. Expl Brain Res. 86, 125-140.
95. Schumacher J. M., Short M. P., Hyman B. T., Breakefield X. O. and Isacson O. (1991) Intracerebral implantation of nerve growth factor-producing fibroblasts protects striatum against neurotoxic levels of excitatory amino acids. Neuroscience 45, 561-570.
96. Schwarcz R., Whetsell W. O. and Mangano R. M. (1983) Quinolinic acid: an endogenous metabolite that produces axon-sparing lesions in rat brain. Science 219, 316-318.
97. Seroogy K. B., Han V. K. M. and Lee D. C. (1991) Regional expression of transforming growth factor a mRNA in the rat central nervous system. Neurosci. Lett. 125, 241-245.
98. Seroogy K. B., Numan S., Gall C. M., Lee D. C. and Kornblum H. I. (1994) Expression of EGF receptor mRNA in rat nigrostriatal system. NeuroReport 6, 105-108.
99. Seroogy K. B., Gall C. M., Lee D. C. and Kornblum H. I. (1995) Proliferative zones of postnatal rat brain express epidermal growth factor receptor mRNA. Brain Res. 670, 157-164.
100. 28K) and parvalbumin immunocytochemistry: localization in the rat hippocampus with specific reference to the selective vulnerability of hippocampal neurons to seizure activity. J. comp. Neurol. 280, 183-196.
101. Sloviter R. S., Sollas A. L., Barbaro N. M. and Laxer K. D. (1991) Calcium-binding protein (calbindin-D28k) and parvalbumin immunocytochemistry in the normal and epileptic human hippocampus. J. comp. Neurol. 308, 381-396.
102. Susel Z., Engber T. M., Kuo S. and Chase T. N. (1991) Prolonged infusion of quinolinic acid into rat striatum as an excitotoxic model of neurodegenerative disease. Neurosci. Lett. 121, 234-238.
103. Sutherland M. K., Wong L., Somerville M. J., Yoong L. K., Bergeron C., Parmentier M. and McLachlan D. R. (1993) Reduction of calbindin-28k mRNA levels in Alzheimer as compared to Huntington hippocampus. Molec. Brain Res. 18, 32-42.
104. Swanson L. W. (1993) Brain Maps: Computer Graphics Files. Elsevier, Amsterdam.
105. The Huntington's Disease Collaborative Research Group (1993) A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 72, 971-983.
106. Timmusk T., Belluardo N., Metsis M. and Persson H. (1993) Widespread and developmentally regulated expression of neurotrophin-4 mRNA in rat brain and peripheral tissues. Eur. J. Neurosci. 5, 605-613.
107. Tobin A. J. (1990) Genetic disorders: Huntington's disease. In Neurobiology of Disease (eds Pearlman A. L. and Collins R. C.), pp. 257-275. Oxford University Press, New York.
108. Uemura Y., Kowall N. W. and Beal M. F. (1990) Selective sparing of NADPH-diaphorase-somatostatin-neuropeptide Y neurons in ischemic gerbil striatum. Ann. Neurol. 27, 620-625.
109. Venero J. L., Beck K. D. and Hefti F. (1994) Intrastriatal infusion of nerve growth factor after quinolinic acid prevents reduction of cellular expression of choline acetyltransferase messenger RNA and trkA messenger RNA, but not glutamate decarboxylase messenger RNA. Neuroscience 61, 257-268.
110. Waldvogel H. J., Faull R. L. M., Williams M. N. and Dragunow M. (1991) Differential sensitivity of calbindin and parvalbumin immunoreactive cells in the striatum to excitotoxins. Brain Res. 546, 329-335.
111. Widmer H. R. and Hefti F. (1994) Neurotrophin-4/5 promotes survival and differentiation of rat striatal neurons developing in culture. Eur. J. Neurosci. 6, 1669-1679.
112. Wilcox J. N. and Derynck R. (1988) Localization of cells synthesizing transforming growth factor-alpha mRNA in the mouse brain. J. Neurosci. 8, 1901-1904.
113. 28K. Brain Res. 526, 303-307.